Trial intelligence / Profile preview

NAC for Liver Function After Mitral Valve Replacement

NCT06486805Phase 4Completed

Sponsor
Kasr Al Ainy Hospital
Start
Jun 2024
Primary completion
Nov 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of acetylcysteine in hepatic dysfunction, oxidative stress, sponsored by Kasr Al Ainy Hospital. Started Jun 2024; status: completed.

02

Drugs

acetylcysteine
03

Conditions

hepatic dysfunctionoxidative stress

Beyond the preview

Go deeper on NCT06486805.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06486805.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call